Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Jimd Reports, Volume 25

Jimd Reports, Volume 25

Patterson, Marc
Morava, Eva
Baumgartner, Matthias

Paperback

Series: Jimd Reports, Book 25

Medical Reference

ISBN10: 3662496674
ISBN13: 9783662496671
Publisher: Springer
Published: Apr 11 2016
Pages: 106
Weight: 0.61
Height: 0.24 Width: 8.25 Depth: 11.00
Language: English
Coenzyme Q10 and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.- Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion.- New Cases of DHTKD1 Mutations in Patients with 2-Ketoadipic Aciduria.- Screening Mucopolysaccharidosis Type IX in Patients with Juvenile Idiopathic Arthritis.- The Pathobiochemistry of Gastrointestinal Symptoms in a Patient with Niemann-Pick Type C Disease.- Improvement of Diffusion Tensor Imaging (DTI) Parameters with Decoppering Treatment in Wilson's Disease.- Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib.- Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI.- The Spectrum of Krabbe Disease in Greece: Biochemical and Molecular Findings.- Exercise Intolerance and Myoglobinuria Associated with a Novel Maternally Inherited MT-ND1 Mutation.- PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?.- Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series.- GM2-Gangliosidosis, AB Variant: Clinical, Ophthalmological, MRI, and Molecular Findings.- LC-MS/MS Analysis of Cerebrospinal Fluid Metabolites in the Pterin Biosynthetic Pathway.- Reduction of plasma globotriaosylsphingosine levels after switching from agalsidase alfa to agalsidase beta as enzyme replacement therapy for Fabry disease.

Also in

Medical Reference

View All